DnaNudge Raises $60M in Series A Funding

31 Aug, 2021

DnaNudge Raises $60M in Series A Funding
Photo by Mikel Parera on Unsplash

– DnaNudge is a London UK-based company focused on genetics testing and medical diagnostics.
– The company raised $60M in Series A funding.
– The round was led by Ventura Capital with participation from Bank Julius Baer.
– The new investment will be used to accelerate the deployment of its rapid genetic testing solutions, including the sample-to-result RT-PCR COVID-19 test (‘CovidNudge’), which is in use in healthcare settings around the world.

Health Care Health Diagnostics Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: